GUIRR COUNCIL MEMBER FULL BIOGRAPHIES
|Dr. Jacques Gansler, GUIRR Co-chair||Mr. Gordon England, GUIRR Co-chair|
|Dr. Tilak Agerwala, IBM [retired]||Dr. Susan Butts, Dow Chemical Company [retired]|
|Dr. Curtis Carlson, SRI International||Dr. Ralph Cicerone, National Academy of Sciences (ex officio)|
|Dr. Francis Collins, National Institute of Health (ex officio)||Dr. France A. Cόrdova, National Science Foundation|
|Dr. Mikael Dolsten, Pfizer, Inc.||Dr. Victor Dzau, Institute of Medicine |
|Dr. John Holdren, Executive Office of the President (ex officio)||Dr. Keith Holterman, Department of Homeland Security|
|Mr. Wayne Johnson, Mass Insight Global Partnerships||Dr. Linda Katehi, University of California at Davis|
|Dr.Ralph Kuncl, University of Redlands||Ms. Gina McCarthy, Environmental Protection Agency|
|Dr. C. D. (Dan) Mote, National Academy of Engineering||Dr. Franklin “Lynn” Orr, U.S. Department of Energy|
|Dr. Stephen Ostroff, U.S. Food & Drug Administration||Dr. Steven Paul, Weill Cornell Medical College|
|Dr. Timothy Persons, U.S. Government Accountability Office||Dr. Luis Proenza, University of Akron|
|Mr. David Spencer, wTE Corporation||Dr. Richard Spinrad, National Oceanic and Atmospheric Administration (ex officio)|
|Dr. Ellen Stofan, National Aeronautics and Space Administration (ex officio)|| Dr. Catherine Woteki, U.S. Department of Agriculture (ex officio)|
The Honorable Dr. Jacques S. Gansler is a Professor and holds the Roger C. Lipitz Chair in Public Policy and Private Enterprise in the School of Public Policy, and is the Director of the Center for Public Policy and Private Enterprise. Additionally, he is the Glenn L. Martin Institute Fellow of Engineering at the A. James Clarke School of Engineering, and an Affiliate Faculty member at the Robert H. Smith School of Business (all at the University of Maryland). He also served as Interim Dean of the School of Public Policy from 2003 to 2004, and as the Vice President for Research for the University of Maryland from 2004-2006.
He is a member of the National Academy of Engineering, and a Fellow of the National Academy of Public Administration.
Previously, Dr. Gansler served as the Under Secretary of Defense for Acquisition, Technology and Logistics from November 1997 until January 2001. In this position, he was responsible for all matters relating to Department of Defense acquisition, research and development, logistics, acquisition reform, advanced technology, international programs, environmental security, nuclear, chemical, and biological programs, and the defense technology and industrial base. (He had an annual budget of over $180 Billion, and a workforce of over 300,000.)
Prior to this appointment, Dr. Gansler was Senior Vice President and Corporate Director for TASC, Incorporated, an applied information technology company, in Arlington, Virginia (from 1977 to 1997). From 1972 to 1977, he served in the government as Deputy Assistant Secretary of Defense (Materiel Acquisition), responsible for all defense procurements and the defense industry; and as Assistant Director of Defense Research and Engineering (Electronics) responsible for all defense electronics Research and Development.
His prior industrial experience included: Vice President (Business Development), I.T.T. (1970-1972); Program Management, Director of Advanced Programs, and Director of International Marketing, Singer Corporation (1962-1970); and Engineering Management, Raytheon Corporation (1956-1962).
Dr. Gansler serves (and has served) on numerous Corporation Boards of Directors, and governmental special committees and advisory boards (e.g., the FAA Blue Ribbon Panel on Acquisition Reform; member of the Federal Emergency Management Agency (FEMA) Advisory Board (10 years); senior consultant to the "Packard Commission" on Defense Acquisition Reform; member of Secretary of Defense’s “Task Force on DoD Nuclear Weapons Management”; and as Chairman of the “Commission on Army Acquisition and Program Management in Expeditionary Operations”). And currently, he is a member of the Defense Science Board, and of the Comptroller Generals’ (GAO) Advisory Board.
He has Chaired numerous Defense Science Board Task Forces (on topics such as “Fulfillment of Urgent Operational Needs”; “Creating an Effective National Security Industrial Base for the 21st Century”; etc.); and he currently Chairs two National Academy Committees (on “Small Business Innovative Research” and on “Human, Machine, Network Integration: Enhanced Data-to-Decisions”).
Additionally, from 1984 to 1997, Dr. Gansler was a Visiting Scholar at the Kennedy School of Government, Harvard University. He is the author of 5 books (“The Defense Industry” (1980); “Affording Defense” (1989); “Defense Conversion” (1995); “Democracy’s Arsenal” (2011) [all MIT Press]; and “Ballistic Missile Defense” (2010) [NDU Press]; a contributing author of 25 other books; author of over 100 papers; and a frequent speaker and Congressional witness (particularly on government acquisition, innovation and commercialization).
Dr. Gansler holds a BE in Electrical Engineering from Yale University, a MS in Electrical Engineering from Northeastern University, a MA in Political Economy from The New School for Social Research, and a Ph.D. in Economics from American University.
Mr. Gordon England is a Chairman of the Board of Directors of V1 Analytical Solutions Inc., a consultant for Fujitsu Defense Systems, and is a General and limited Partner of GLILOT Capital Partners, an Israeli private equity firm.
Previously, Mr. England served as the 29th Deputy Secretary of Defense. He also served as the 72nd and 73rd Secretary of the Navy and as the first Deputy Secretary of the Department of Homeland Security.
Prior to joining the federal government, Mr. England served as President of the General Dynamics Fort Worth Division (later Lockheed Martin Aeronautics Company); as Vice President of Engineering at General Dynamics Land Systems and later as President; and as corporate Executive Vice President of General Dynamics Information Systems and Technology Sector, Ground Combat Systems Sector and the International Sector. His business career spanned over 40 years as an engineer specializing in aerospace avionics and in senior executive positions. Mr. England is a member of the prestigious National Academy of Engineering.
A native of Baltimore, Mr. England graduated from the University of Maryland in 1961 with a bachelor’s degree in electrical engineering. In 1975 he earned a master’s degree in business administration from the M.J. Neeley School of Business at Texas Christian University. He is a Distinguished Alumnus of both Universities. He is a member of business, engineering and leadership honor societies. He serves on the board of Trustees for the University of Maryland and is Chairman of the Foundation Board for the U.S. Naval Institute.
Mr. England has served in a variety of civic, charitable and government organizations, including serving as a city councilman; Vice Chair, national Board of Goodwill, International; the USO’s Board of Governors; the Defense Science Board; the Board of Visitors at Texas Christian University; and many others. He has been recognized for numerous professional and service contributions by universities, professional and civic organizations, local government and the Department of Defense.
Dr. Tilak Agerwala
has been vice president, Systems at IBM Research. He was responsible for developing the next-generation systems hardware and software technologies for IBM's Blue Gene Supercomputers, mainframe and Unix computers, storage systems, and data center networking. Dr. Agerwala joined IBM at the T.J. Watson Research Center and has held executive positions at IBM in research, advanced development, development, marketing and business development. His research interests are in the area of high performance computer architectures and systems. Dr. Agerwala received the W. Wallace McDowell Award from the IEEE in 1998 for “outstanding contributions to the development of high performance computers.” He is a founding member of the IBM Academy of Technology. He is a Fellow of the Institute of Electrical and Electronics Engineers. He received his B.Tech. in electrical engineering from the Indian Institute of Technology, Kanpur, India and his Ph.D. in electrical engineering from the Johns Hopkins University, Baltimore, Maryland
Dr. Susan Butts
is an active member of the science and technology policy community following her 31 year career in the chemical industry and related organizations. Most recently she served as the President of the Council for Chemical Research (CCR), a non-profit organization whose purpose is to benefit society by advancing research in chemistry and related disciplines through leadership collaboration across discipline, institution, and sector boundaries. Before joining CCR she worked for The Dow Chemical Company for three decades in various positions in the Research and Development organization. From 2001 through 2009 she served first as Director of External Technology then as Senior Director of External Science & Technology Programs. In that capacity she was responsible for Dow’s sponsored research programs at over 150 universities, institutes, and national laboratories worldwide and also for Dow’s contract research activities with U.S. and European government agencies. During the last four years in this position she worked on issues related to science policy and government funding for research and development from Dow’s office in Washington, DC. Before joining the External Technology group Dr. Butts held several other positions at Dow including Senior Resource Leader for Atomic Spectroscopy and Inorganic Analysis within the Global Analytical Sciences Laboratory, Manager of Ph.D. Hiring and Placement, Safety and Regulatory Affairs Manager for Central Research, and Principal Investigator on various catalysis research projects in Central Research. Dr. Butts is past president of the University-Industry Demonstration Partnership, an organization in the National Academies which works to strengthen research collaborations between universities and industry. Currently, she is a member of the Council of the Government-University-Industry Research Roundtable (GUIRR) in the National Academies, member of the board of directors of the Alliance for Science and Technology Research in America (ASTRA), member of the Committee on Science, Engineering and Public Policy in the American Association for the Advancement of Science (AAAS), member of the Advisory Committee for the SBIR/STTR Program in the National Science Foundation, and member of several committees of the American Chemical Society (ACS). Dr. Butts holds the degrees of B.S. in Chemistry from the University of Michigan and Ph.D. in chemistry from Northwestern University.
Dr. Curtis R. Carlson is the Vice Chairman for Innovation for SRI International, In December 1998, he became their president and CEO. Previously, he spent more than 20 years with Sarnoff Corporation, an SRI subsidiary that was fully integrated into SRI in 2011. In 1973, Carlson joined RCA Laboratories, which became part of SRI in 1987 as Sarnoff Corporation. He started and helped lead the high-definition television (HDTV) program that became the U.S. standard, and in 1997 his team won an Emmy Award for outstanding technical achievement. In 2000, another team started and led by Carlson won an Emmy for a system to optimize satellite broadcast image quality. He helped found more than 12 companies. Carlson is widely sought out as a speaker and thought leader on innovation and global competitiveness. He serves as co-chairman of the Scientific Advisory Board of the Singapore National Research Foundation. He is a founding member of the Innovation Leadership Council for the World Economic Forum and was selected to serve on President Obama's National Advisory Council on Innovation and Entrepreneurship. He advises U.S. governors and prime ministers, economic ministers, and education ministers around the world on innovation, competitiveness, and educational reform. In 2006, Carlson won the Otto Schade Prize for Display Performance and Image Quality from the Society for Information Display with Dr. Roger Cohen. In 2007, Carlson was given the Medal of Excellence Award by Rutgers University's School of Engineering. In 2002, he received the Dr. Robert H. Goddard Award from Worcester Polytechnic Institute (WPI) for his professional achievements. He has received honorary degrees from Worcester Polytechnic Institute, Stevens Institute of Technology, and Kettering University. He was a visiting distinguished scientist at the University of Washington in 1998, and he is a Kobe ambassador for SRI's contributions to Kobe, Japan. Carlson has been on numerous boards, including Nuance Communications, Pyramid Vision, Sensar, and Sarif. He was a member of General Motors' Science and Technology Advisory Board. He has served on numerous government task forces, including the Air Force Scientific Advisory Board, National Research Laboratory Review Panels, the Galvin Naval Research Laboratory Review Panel, the U.S. Army Research Laboratory Technical Assessment Board, and the Defense Science Board task force on bio-chemical defense. He was a member of the original team that helped create the Army's Federated Laboratories. He has written a book with William Wilmot called Innovation: The Five Disciplines for Creating What Customers Want, published by Random House. It was selected by BusinessWeek as one of the Top Ten Business Books for 2006. Innovation describes how SRI's unique process for innovation can be applied to all types of commercial and nonprofit enterprises, including the government. Carlson received his B.S. in physics from WPI and was named in Who's Who Among Students. He is a member of Sigma Xi, and Tau Beta Pi. His M.S. and Ph.D. degrees are from Rutgers University. Carlson has published or presented numerous technical publications and holds fundamental patents in the fields of image quality, image coding, and computer vision.
Dr. Ralph J. Cicerone is President of the National Academy of Sciences and Chair of the National Research Council. Dr. Cicerone is an atmospheric scientist whose research in atmospheric chemistry and global climate change has involved him in shaping science and environmental policy at the highest levels nationally and internationally. He served as president of the American Geophysical Union, the world's largest society of earth scientists. He has published 100 refereed papers and 200 conference papers, including a citation classic as recognized by the Institute for Scientific Information. In 2001, he led a National Academy of Sciences study, requested by President Bush, on the current state of climate change and its impact on the environment and human health. Prior to his election as Academy president, Dr. Cicerone was at the University of California, Irvine where he served as the Daniel G. Aldrich Professor of Earth System Science, as the founding chair of the Department of Earth System Science from 1989 to 1994, as Dean of the School of Physical Sciences from 1994 to 1998, and chancellor from 1998 to 2005. Dr. Cicerone’s research was recognized on the citation for the 1995 Nobel Prize in Chemistry awarded to University of California, Irvine colleague F. Sherwood Rowland. He received the United Nations Environment Program Ozone Award in 1997. The Franklin Institute recognized his outstanding contributions to the understanding of greenhouse gases and ozone depletion and his fundamental research in biogeochemistry by selecting Dr. Cicerone as the 1999 laureate for the Bower Award and Prize for Achievement in Science. One of the most prestigious American awards in science, the Bower Prize also recognized his public policy leadership in protecting the global environment. The American Geophysical Union awarded him both its 1979 James B. Macelwane Award for outstanding contributions to geophysics by a young scientist and its 2002 Roger Revelle Medal for outstanding research contributions to the understanding of Earth’s atmospheric processes, biogeochemical cycles, and other key elements of the climate system. In 2004, the World Cultural Council honored him with another of the scientific community’s most distinguished awards, the Albert Einstein World Award in Science. Dr. Cicerone is a member of the National Academy of Sciences, the American Academy of Arts and Sciences, the American Philosophical Society, the Russian Academy of Sciences, and Academia Nazionale dei Lincei (Rome).
Dr. Francis S. Collins
was officially sworn in on Monday, August 17, 2009 as the 16th director of the National Institutes of Health (NIH). Dr. Collins was nominated by President Barack Obama on July 8, and was unanimously confirmed by the U.S. Senate on August 7. Dr. Collins, a physician-geneticist noted for his landmark discoveries of disease genes and his leadership of the Human Genome Project, served as director of the National Human Genome Research Institute (NHGRI) at the NIH from 1993-2008. With Dr. Collins at the helm, the Human Genome Project consistently met projected milestones ahead of schedule and under budget. This remarkable international project culminated in April 2003 with the completion of a finished sequence of the human DNA instruction book. In addition to his achievements as the NHGRI director, Dr. Collins' own research laboratory has discovered a number of important genes, including those responsible for cystic fibrosis, neurofibromatosis, Huntington's disease, a familial endocrine cancer syndrome, and most recently, genes for type 2 diabetes and the gene that causes Hutchinson-Gilford progeria syndrome. Dr. Collins has a longstanding interest in the interface between science and faith, and has written about this in The Language of God: A Scientist Presents Evidence for Belief (Free Press, 2006), which spent many weeks on The New York Times bestseller list. He is the author of a new book on personalized medicine, The Language of Life: DNA and the Revolution in Personalized Medicine (HarperCollins, to be published in early 2010). Dr. Collins received a B.S. in chemistry from the University of Virginia, a Ph.D. in physical chemistry from Yale University, and an M.D. with honors from the University of North Carolina at Chapel Hill. Prior to coming to the NIH in 1993, he spent nine years on the faculty of the University of Michigan, where he was a Howard Hughes Medical Institute investigator. He is an elected member of the Institute of Medicine and the National Academy of Sciences. Dr. Collins was awarded the Presidential Medal of Freedom in November 2007. In a White House ceremony on October 7, 2009, Dr. Collins received the National Medal of Science, the highest honor bestowed on scientists by the United States government.
Dr. Francis A Cόrdova is the 14th director of the National Science Foundation (NSF). Córdova leads the only government science agency charged with advancing all fields of scientific discovery, technological innovation, and science, technology, engineering and mathematics (STEM) education.
Córdova is president emerita of Purdue University, where she served as president. She led the University of California, Riverside, as chancellor and was a distinguished professor of physics and astronomy. Córdova was the vice chancellor for research and professor of physics at the University of California, Santa Barbara.
Córdova served as NASA's chief scientist. Prior to joining NASA, she was on the faculty of the Pennsylvania State University where she headed the department of astronomy and astrophysics. Córdova was deputy group leader in the Earth and space sciences division at Los Alamos National Laboratory and staff scientist. She received her B.A. from Stanford University and her Ph.D in physics from the California Institute of Technology.
More recently, Córdova served as chair of the Board of Regents of the Smithsonian Institution and on the board of trustees of Mayo Clinic. She served as a member of the National Science Board (NSB). As NSF director, she is an ex officio member of the NSB.
|Dr. Mikael Dolsten is the President of Worldwide Research and Development, advancing Pfizer's leadership in small molecule science and medicines, as well as its leadership, expertise, and innovation in the areas of biotherapeutics and vaccines. Worldwide R&D combines entrepreneurial Biotech Units with core platforms; Research Units with deep disease area expertise; and broad multi disciplinary scientific expertise to discover innovative therapeutic programs in biotherapeutics, vaccines and small molecules. Mikael is also co-chair of the company's Portfolio Strategy and Investment (PSI) Committee, which governs major pipeline investments and strategic R&D priorities. Pfizer scientists across WRD apply industry-leading scientific and technological expertise across a range of small molecule and biologic platforms and modalities. In a global network of research laboratories and clinical study sites, Pfizer R&D professionals and business unit colleagues focus on translating deep science into safe and effective drugs to prevent, treat and cure disease. Mikael oversees all Pfizer research units and biotech units in PharmaTherapeutics and BioTherapeutics: Antibacterials; Cardiovascular, Metabolic & Endocrine Diseases; Internal Medicine; Neuroscience; Oncology; Pain & Sensory Disorders; Regenerative Medicine; Indications Discovery; Inflammation & Immunology; Orphan & Genetic Diseases; Center for Therapeutic Innovation; Vaccine R&D; CovX; Rinat; and Oligonucleotide Therapeutics. WRD also includes these global science-based groups: Medicinal Chemistry; Drug Safety R&D; Pharmaceutical Sciences; Pharmacokinetics, Dynamics & Metabolism; Comparative Medicine; Clinical Research; Clinical Programs; Development Operations; Development & Strategic Operations; External R&D Innovation; Research Centers of Emphasis; and Asia R&D. Previously, Mikael was President of BioTherapeutics R&D, responsible for driving Pfizer leadership, expertise, and innovation in biologic medicines and vaccines. Prior to joining Pfizer in 2009, Mikael was Senior Vice President, Wyeth Inc., and President of Wyeth Research where he led scientists across the U.S., Europe and Asia in the research and development of small molecules, vaccines and protein-based medicines in Inflammation, Women's Health, Neuroscience, Oncology, Infectious Diseases (vaccines, antibiotics), Hemophilia, GI and Musculoskeletal Diseases. Before joining Wyeth, Mikael served as Executive Vice President within Pharmaceutical Research & Development / Medicine at Boehringer Ingelheim. He led pharmaceutical research in the U.S., Canada, Germany, Italy, Austria and Japan - with programs in respiratory, inflammation / immunology, oncology, virology, cardiovascular, metabolism and CNS. He was a member of the BI corporate management team responsible for all worldwide development projects and licensing opportunities. Mikael's earlier career included research leader positions with AstraZeneca, Pharmacia and Upjohn. Mikael earned his Ph.D. in tumor immunology and M.D. from the University of Lund in Sweden. He also studied virology and cell biology at the Weizmann Institute in Israel and has been appointed as Adjunct Professor in Immunology at the Medical Faculty in Lund. In July 2010, Mikael was elected a fellow of the New York Academy of Medicine. He is an appointed Governor of the New York Academy of Sciences. A member of the Science and Regulatory Executive Committee of The Pharmaceutical Research and Manufacturers of America (PhRMA), Mikael also serves on the PhRMA Foundation Board of Directors. Mikael has published several patents and about 150 articles in international journals with particular contributions in areas such as molecular cell biology, immunology and oncology. |
Dr. Victor Dzau is the eighth President of the Institute of Medicine (IOM). He is Chancellor Emeritus and James B. Duke Professor of Medicine at Duke University and the past President and CEO of the Duke University Health System. Previously, Dr. Dzau was the Hersey Professor of Theory and Practice of Medicine and Chairman of Medicine at Harvard Medical School’s Brigham and Women’s Hospital, as well as Chairman of the Department of Medicine at Stanford University.
Dr. Dzau has made a significant impact on medicine through his seminal research in cardiovascular medicine and genetics, his pioneering of the discipline of vascular medicine, and his leadership in health care innovation. His important work on the renin angiotensin system (RAS) paved the way for the contemporary understanding of RAS in cardiovascular disease and the development of RAS inhibitors as widely used, lifesaving drugs. Dr. Dzau also pioneered gene therapy for vascular disease, and his recent work on stem cell paracrine mechanisms and the use of microRNA in direct reprogramming provides novel insight into stem cell biology and regenerative medicine.
In his role as a leader in health care, Dr. Dzau has led efforts in health care innovation. His vision is for academic health sciences centers to lead the transformation of medicine through innovation, translation, and globalization. Leading this vision at Duke, he and his colleagues developed the Duke Translational Medicine Institute, the Duke Global Health Institute, the Duke-National University of Singapore Graduate Medical School, and the Duke Institute for Health Innovation. These initiatives create a seamless continuum from discovery and translational sciences to clinical care, and they promote transformative innovation in health.
As one of the world’s preeminent academic health leaders, Dr. Dzau advises governments, corporations, and universities worldwide. He has been a member of the Council of the IOM and the Advisory Committee to the Director of the National Institutes of Health (NIH), as well as Chair of the NIH Cardiovascular Disease Advisory Committee and the Association of Academic Health Centers. He served on the Governing Board of the Duke-National University of Singapore Graduate Medical School and the Board of Health Governors of the World Economic Forum and chaired its Global Agenda Council on Personalized and Precision Medicine. He also served as the Senior Health Policy Advisor to Her Highness Sheikha Moza (Chair of the Qatar Foundation). Currently, he is a member of the Board of Directors of the Singapore Health System, the Expert Board of the Imperial College Health Partners, UK, and the International Advisory Board of the Biomedical Science Council of Singapore. In 2011, he led a partnership between Duke University, the World Economic Forum, and McKinsey, and he founded the International Partnership for Innovative Healthcare Delivery and currently chairs its Board of Directors.
Among his honors and recognitions are the Gustav Nylin Medal from the Swedish Royal College of Medicine; the Max Delbruck Medal from Humboldt University, Charité, and the Max Planck Institute; the Commemorative Gold Medal from the Ludwig Maximilian University of Munich; the Inaugural Hatter Award from the Medical Research Council of South Africa; the Polzer Prize from the European Academy of Sciences and Arts; the Novartis Award for Hypertension Research; the Distinguished Scientist Award from the American Heart Association (AHA); and the AHA Research Achievement Award for his contributions to cardiovascular biology and medicine. Recently, he was awarded the Public Service Medal by the President of Singapore. He has received six honorary doctorates.
Dr. John P. Holdren
is Assistant to the President for Science and Technology, Director of the White House Office of Science and Technology Policy, and Co-Chair of the President’s Council of Advisors on Science and Technology (PCAST). Prior to this appointment, he was the Teresa and John Heinz Professor of Environmental Policy at the Kennedy School of Government at Harvard University and director of the Science, Technology, and Public Policy Program at the School's Belfer Center for Science and International Affairs. Holdren earned a bachelor's degree from MIT in 1965 and a PhD in plasma physics from Stanford University in 1970. He taught at the University of California, Berkeley for more than two decades. His work has focused on global environmental change, energy technologies and policies, nuclear proliferation, and science and technology policy. Dr. Holdren served as chairman of the board of directors of the American Association for the Advancement of Science from February 2007 until February 2008 (AAAS) and is director of the Woods Hole Research Center. Dr. Holdren is the author of some 300 articles and papers, and he has co-authored and co-edited some 20 books and book-length reports, such as Energy (1971), Human Ecology (1973), Ecoscience (1977), Energy in Transition (1980), Earth and the Human Future (1986), Strategic Defenses and the Future of the Arms Race (1987), Building Global Security Through Cooperation (1990), Conversion of Military R&D (1998), and Ending the Energy Stalemate (2004). Holdren opposes the use of nuclear weapons to respond to chemical and biological attacks on Americans. He is the chair of the advisory board for Innovations, a quarterly journal about entrepreneurial solutions to global challenges published by MIT Press.
Dr. Keith Holterman
, DrPH, MPH, RN is the Director of National Training, Education and Exercises Division for the Department of Homeland Security's Federal Emergency Management Agency (FEMA). He has more than 35 years of experience in the emergency services field.
Prior to joining FEMA, Dr. Holtermann was the Associate Dean for Health Sciences at The George Washington University (GW) School of Medicine and Health Sciences and served on assignment with FEMA as their founding Director of the National Exercise and Simulation Center. While also at GW, Dr. Holtermann served on a four-year assignment with the U.S. Department of Health and Human Services (HHS) in the Office of the Assistant Secretary for Preparedness and Response in a variety of executive leadership charges. At HHS, he worked as the Emergency Operations Branch chief and the Training Exercises and Lessons Learned lead; he also opened and led the Office of International Response Policy.
Prior to joining GW, Dr. Holtermann served as Director of Emergency Medical Services (EMS) for Jersey City and paramedic coordinator for Hudson County, New Jersey; forensic investigator for the Hudson County, New Jersey, State Medical Examiners Office; director of EMS for the country of Costa Rica; a Health Officer at the U.S. Embassies in Costa Rica and Nicaragua for the U.S. Department of State; and inspector and monitor for the Strategic Arms Reduction and Intermediate-Range Nuclear Forces treaties in Russia. He has also been on faculty at multiple colleges and universities.
Dr. Holtermann spent more than 30 years practicing clinically as a Paramedic, Certified Emergency Nurse, Trauma Nurse Team leader, former Disaster Medical Assistance Team member, and Basic and Advanced Cardiac Life Support instructor. Dr. Holtermann received a Bachelor of Science in Nursing from New York University; a Master's of Business Administration from National University; Master’s of Public Health from San Diego State University; and a Doctor of Public Health from Johns Hopkins University with a concentration in Health Policy.
|Wayne C. Johnson is Director of Innovation Partnerships at Mass Insight Global Partnerships in Boston. In his position, he is responsible for implementing a new collaboration model between industry, university and government at the state and regional level. In his previous position he was Executive Director of the UMass Lowell Innovation Institute where he was also founded. Prior to that position he was Assistant Vice President for Institute Corporate Relations at Caltech. Mr. Johnson has a background of extensive corporate experience serving as Vice President of University Relations Worldwide at HP, Manager of University Relations at Microsoft and various management positions at Raytheon Company. He is recognized as a leader internationally for developing and leveraging partnerships among corporations, key universities, and government agencies, to accelerate global transfer and acquisition of talent and knowledge. He has been an Adjunct Professor of Management at Boston University for 19 years and received a MBA from Boston College and a BA from Colgate University.|
Dr. Linda Katehi became the sixth chancellor of the University of California, Davis, on August 17, 2009. As chief executive officer, she oversees all aspects of the university’s teaching, research and public service mission. Chancellor Katehi also holds UC Davis faculty appointments in electrical and computer engineering and in women and gender studies. A member of the National Academy of Engineering, she chaired until 2010 the President’s Committee for the National Medal of Science and the Secretary of Commerce’s committee for the National Medal of Technology and Innovation. She is a fellow of the American Association for the Advancement of Science and the American Academy of Arts and Sciences, and is a member of many other national boards and committees. Previously, Chancellor Katehi served as provost and vice chancellor for academic affairs at the University of Illinois at Urbana-Champaign; the John A. Edwardson Dean of Engineering and professor of electrical and computer engineering at Purdue University; and associate dean for academic affairs and graduate education in the College of Engineering and professor of electrical engineering and computer science at the University of Michigan. Since her early years as a faculty member, Chancellor Katehi has focused on expanding research opportunities for undergraduates and improving the education and professional experience of graduate students, with an emphasis on underrepresented groups. She has mentored more than 70 postdoctoral fellows, doctoral and master’s students in electrical and computer engineering. Twenty-two of the 44 doctoral students who graduated under her supervision have become faculty members in research universities in the United States and abroad. Her work in electronic circuit design has led to numerous national and international awards both as a technical leader and educator, 19 U.S. patents, and an additional five U.S. patent applications. She is the author or co-author of 10 book chapters and about 650 refereed publications in journals and symposia proceedings. She earned her bachelor’s degree in electrical engineering from the National Technical University of Athens, Greece, in 1977, and her master’s and doctoral degrees in electrical engineering from UCLA in 1981 and 1984, respectively.
Dr. Ralph Kuncl is Provost and Executive Vice President for the University of Rochester. He is responsible for overseeing the academic integrity of the entire institution. Those who report to the Provost include the Deans and Directors of the various schools and organizations within the University including the Eastman School of Music, the Simon School of Business, the Warner Graduate School of Education, Information Technology, River Campus Libraries, Faculty Development and Diversity, the Center for Entrepreneurship, the Memorial Art Gallery, and the Laboratory for Laser Energetics. Dr. Kuncl is a national leader in the neurosciences, having distinguished himself at Johns Hopkins University, where he was a professor of neurology, pathology, and cellular and molecular medicine at the School of Medicine from 1983 to 2002. While there, his lab discovered the glutamate transporter defect in the disease commonly known as ALS or Lou Gehrig’s Disease. The discovery changed the field and helped lead to the first effective treatment for the disease. In a recent achievement, he orchestrated a public/private alliance between the University of Rochester and a major international corporation to create what will be the world’s largest center of high performance computing devoted to health sciences. Dr. Kuncl has authored over 150 scholarly publications, edited scholarly journals, earned numerous fellowships, and received many honors, including the Frank Ford Award for outstanding teaching in neurosciences at Johns Hopkins School of Medicine and the Distinguished Service Award of the University of Chicago. He has trained numerous post-graduate and undergraduate students who have gone on to named fellowships and research awards themselves. His scholarship includes highly cited research in motor neuron pathobiology, neuromuscular disorders, drug development, and federal funding for research in higher education. He earned his Ph.D. and M.D. degrees from the University of Chicago.
|Ms. Gina McCarthy is the Administrator of the U.S. Environmental Protection Agency. |
Appointed by President Obama in 2009 as Assistant Administrator for EPA’s Office of Air and Radiation, Gina McCarthy has been a leading advocate for common-sense strategies to protect public health and the environment.
Previously, McCarthy served as the Commissioner of the Connecticut Department of Environmental Protection. During her career, which spans over 30 years, she has worked at both the state and local levels on critical environmental issues and helped coordinate policies on economic growth, energy, transportation and the environment.
McCarthy received a Bachelor of Arts in Social Anthropology from the University of Massachusetts at Boston and a joint Master of Science in Environmental Health Engineering and Planning and Policy from Tufts University.
Dr. C. D. (Dan) Mote, Jr.
is President of the National Academy of Engineering and Regents Professor, on leave, from the University of Maryland, College Park.
Dr. Mote is a native Californian who earned his BS, MS, and PhD degrees at the University of California, Berkeley in mechanical engineering between 1959 and 1963. After a postdoctoral year in England and three years as an assistant professor at the Carnegie Institute of Technology in Pittsburgh, he returned to Berkeley to join the faculty in mechanical engineering for the next 31 years. He and his students investigated the dynamics, stability, and control of high-speed rotating and translating continua (e.g., disks, webs, tapes, and cables) as well as biomechanical problems emanating from snow skiing. He coined the area called “dynamics of axially moving materials” encompassing these systems. Fifty-eight PhD students earned their degrees under his mentorship.
At Berkeley, he held an endowed chair in mechanical systems and served as chair of the mechanical engineering department from 1987 to 1991 when the National Research Council (NRC) ranked its graduate program effectiveness highest nationally. Because of his success at raising funds for mechanical engineering, in 1991 he was appointed vice chancellor at Berkeley expressly to create and lead a $1 billion capital campaign for the campus that ultimately reached $1.4 billion.
In 1998, Dr. Mote was recruited to the presidency of the University of Maryland, College Park, a position he held until 2010 when he was appointed Regents Professor. His goal for the university was to elevate its self-expectation of achievement and its national and global position through proactive initiatives. During his tenure the number of Academy members among the faculty tripled, three Nobel laureates were recognized, and an accredited school of public health and a new department of bioengineering were created. He also founded a 130-acre research park next to the campus, faculty research funds increased by 150%, and partnerships with surrounding federal agencies and with international organizations expanded greatly. The number of students studying abroad tripled, and he created an annual open house day that has attracted over 100,000 visitors on that day, founded a charitable foundation for the campus whose board of trustees launched a $1 billion capital campaign that reached its goal, and took every student to lunch that wanted to go. The Academic Ranking of World Universities ranked the campus #36 in 2010 and its Engineering School #13 globally.
The NAE elected him to membership in 1988, and to the positions of Councillor (2002-2008), Treasurer (2009-2013), and President for six years beginning July 1, 2013. He has served on the NRC Governing Board Executive Committee since 2009. He chaired the NRC Committee on Global Science and Technology Strategies and Their Effects on US National Security (2009-2010), cochaired the National Academies Government-University-Industry Research Roundtable (2007-2013), and cochaired the Committee on Science, Technology, Engineering, and Mathematics Workforce Needs for the US Department of Defense and the US Industrial Base (2011-2012). He was vice chair of the NRC Committee on the Department of Defense Basic Research (2004) and served on the NRC committee authoring the Rising Above the Gathering Storm reports of 2005 and 2010. He was also a founding member of the FBI’s National Security Higher Education Advisory Board (2005-2010).
Dr. Mote’s recognitions include the NAE Founders Award, the American Society of Mechanical Engineers Medal, and the Humboldt Prize of the Federal Republic of Germany. At the University of California, Berkeley, he was honored with the Distinguished Teaching Award, Distinguished Engineering Alumnus Award, Berkeley Citation, and Excellence in Achievement Award. He is an Honorary Fellow of the American Society of Mechanical Engineers, and Fellow of the American Academy of Arts and Sciences, the American Academy of Mechanics, the Acoustical Society of America and the American Association for the Advancement of Science. He holds three honorary doctorates and two honorary professorships.
|Dr. Franklin “Lynn” Orr|
*Bio & Photo Coming Soon*
|Dr. Stephen Ostroff|
*Bio & Photo Coming Soon*
Dr. Steven M. Paul is the Director of the Helen and Robert Appel Alzheimer’s Disease Research Institute and Professor of Neuroscience and Psychiatry at Weill Cornell Medical College. He was formerly the Executive Vice President of Science and Technology and President of the Lilly Research Laboratories (LRL) of Eli Lilly and Company. Prior to assuming his positions at Lilly and Weill Cornell Medical College, Dr. Paul served as Scientific Director of the National Institute of Mental Health (NIMH/NIH) in Bethesda, Maryland. Dr. Paul is a member of various professional and honorary societies, which include Phi Eta Sigma; Alpha Epsilon Delta; Sigma Xi; Phi Beta Kappa; and the Alpha Omega Alpha Honorary Medical Society. He is the recipient of many honors and scientific recognitions, including: The Distinguished Service Medal of the USPHS and the Chief Scientific Officer of the Year Award. In 1997, Dr. Paul was elected to membership in the Institute of Medicine (IOM) of the National Academy of Sciences and currently serves on the IOM’s Board on Health Sciences Policy. In 2009 Dr. Paul was elected a Fellow of the American Association for the Advancement of Science (AAAS) . Dr. Paul has authored or co-authored over 500 papers and invited book chapters and was listed as one of the most highly cited scientists in the world (top 50 in Neuroscience) (1980-2000) by the Institute for Scientific Information (I.S.I.), Philadelphia, Pennsylvania. He holds 9 patents on inventions made both at NIH and Lilly. His current work has focused on the role of apoE in the pathogenesis of Alzheimer’s disease. He is also an inventor of solanezumab, a humanized anti-Aβ monoclonal antibody currently in late-stage clinical testing by Lilly as a potential disease-modifying treatment for Alzheimer’s disease.
Dr. Timothy M. Persons was appointed the Chief Scientist of the United States Government Accountability Office (GAO - the investigative arm of the U.S. Congress) in July of 2008. As such, he is a member of the Senior Executive Service of the U.S. federal government. In addition to leading advanced data analytics activities at GAO, he also serves to co-direct GAO’s Center for Science, Technology, and Engineering (CSTE), a group of highly specialized scientists, engineers, mathematicians, and information technologists. In these roles he is an expert advisor and chief consultant to the GAO, Congress, and other federal agencies and government programs on cutting-edge science and technology (S&T), key highly-specialized national and international systems, engineering policies, best practices, and original research studies in the fields of engineering, computer, and the physical and biological sciences to ensure efficient, effective, and economical use of science and technology in government programs. He has led Technology Assessments and scientific studies for the U.S. Congress on topics ranging from additive manufacturing, nanomanufacturing, biodetection systems, homeland security imaging and nuclear detection systems, freshwater conservation technologies, and climate engineering technologies. Prior to joining GAO, Dr. Persons held key leadership roles in the National Security Community.
Dr. Persons is a 2014 recipient of a GAO Distinguished Service Award, a 2012 recipient of the Arthur S. Flemming award in recognition of sustained outstanding and meritorious achievement within the U.S. federal government; and a 2012 recipient of GAO’s Big Picture Award for significant project achievement involving the ability to look longer, broader, and more strategically at key national or global issues. In 2007, Dr. Persons was awarded a Director of National Intelligence Science and Technology Fellowship focusing on computational imaging systems research. He was also selected as the James Madison University (JMU) Physics Alumnus of 2007. He has also served as a radiation physicist with the University of North Carolina at Chapel Hill. He received his B.Sc. (Physics) from JMU, a M.Sc. (Nuclear Physics) from Emory University, and a M.Sc. (Computer Science) and Ph.D. (Biomedical Engineering) degrees from Wake Forest University. He is a senior member of the Institute for Electrical and Electronic Engineers (IEEE), serves as a council member of the National Academy of Sciences’ (NAS) Government-University-Industry Research Roundtable (GUIRR) as well as the World Future Society Global Advisory Council, and has authored or co-authored an array of journal, conference, and technical articles.
Dr. Luis M. Proenza is chief executive officer of The University of Akron. Under his leadership, the university has financed more than $625 million in capital construction to completely transform its campus. Dr. Proenza also has led community efforts to create two key enterprises: a University Park Alliance that is revitalizing a 50-block area surrounding campus and the $200-million Austen BioInnovation Institute in Akron, a partnership with three area hospitals and a medical school, to establish Akron as a center for biomaterials and biomedicine. He has participated in national science and technology policy matters since the 1970s, serving in positions as: study director of the National Research Council-National Academy of Sciences' Committee on Vision; The University of Georgia's Liaison for Science and Technology Policy; a member of the National Biotechnology Policy Board-National Institutes of Health; and Advisor for Science and Technology Policy to the Governor of Alaska. In 1992, U.S. President George H. W. Bush appointed Dr. Proenza to the U.S. Arctic Research Commission. Dr. Proenza became its vice chairman. He later was Chair of the Science and Mathematics Education Task Force for the Secretary of Energy Advisory Board. In 2001, President George W. Bush named Dr. Proenza to the President's Council of Advisors on Science and Technology, the nation's highest-level, policy-advisory group for science and technology. Dr. Proenza co-chaired PCAST's committee on Public-Private Partnerships and worked on panels on U.S. Research and Development Investments, Technology Transfer, Alternative Energy, Energy Efficiency and Advanced Manufacturing, Personalized Medicine, Information Technology, and Nanotechnology. He now serves on the Council on Competitiveness' executive committee and its Manufacturing Competitiveness Steering Committee, and chairs its Regional Leadership Institute Steering Committee. Recently, Dr. Proenza was appointed to the Council of the Government-University-Industry Research Roundtable of the National Academies and to the Technology Innovation Program Advisory Board for the National Institute of Standards and Technology. He also is a member of the Council on Foreign Relations and a board member of the States Science and Technology Institute. Prior to his appointment at Akron, Dr. Proenza was Vice President for Research and Dean of the Graduate School at Purdue University. He also served the University of Alaska first as Vice Chancellor for Research and Dean of the Graduate School, then as Vice President for Academic Affairs and Research. After earning a B.A. from Emory University (1965), M.A. from The Ohio State University (1966) and Ph.D. from the University of Minnesota (1971), Dr. Proenza joined the faculty of the University of Georgia in 1971. There, his research in psychology and neurobiology was continuously supported by grants from the National Eye Institute, including a Research Career Development Award.
Mr. Dave Spencer
is Chairman and Chief Technical Officer of wTe Corporation, a company he founded in 1981, located in Bedford, Massachusetts where he served as President and CEO from 1981 to 2007. In its early years, wTe was a venture capital funded high growth company, listed on the prestigious Inc 500 three times and on the New England 100 twice. Historically, wTe was in the waste-to-energy business and focused on turning around and operating 3rd party owned facilities that burned trash to produce steam, chilled water, hot water and electricity. The company’s particular expertise was in design and operation of refuse derived fuel (RDF) technologies. wTe is now focused on recovery of metals and plastics from scrap and waste. Education
: Dave earned his B.S. degree with honors in Metallurgical Engineering from Lafayette College where he was a General Motors Scholar, a member of Tau Beta Pi, and Sigma Xi. He received his Doctor of Science in Materials Science at the Massachusetts Institute of Technology. While at M.I.T., as part of his Doctoral Thesis, he invented the Rheocasting process, a transformational technology that has evolved into its own field of science. Rheocasting and Thixocasting are now practiced worldwide. Today, wTe is privately held with 2008 revenues of about $90 million. Dave’s most recent activities are largely directed toward development and commercialization of a new high speed optoelectronic sorting and sensor technology, called the Spectramet Technology which is the subject of his presentation. Spectramet could revolutionize the way scrap is processed saving energy and preserving scarce energy resources. The National Science Foundation has provided substantial support to this activity under its NSF SBIR program. Funding was also provided by the National Institute of Standards and Technology under its Advanced Technology Program.
|Dr. Richard Spinrad|
*Bio & Photo Coming Soon*
Dr. Ellen Stofan was appointed NASA chief scientist on August 25, 2013, serving as principal advisor to NASA Administrator Charles Bolden on the agency's science programs and science-related strategic planning and investments.
Prior to her appointment, Stofan was vice president of Proxemy Research in Laytonsville, Md., and honorary professor in the department of Earth sciences at University College London in England. Her research has focused on the geology of Venus, Mars, Saturn's moon Titan, and Earth. Stofan is an associate member of the Cassini Mission to Saturn Radar Team and a co-investigator on the Mars Express Mission's MARSIS sounder. She also was principal investigator on the Titan Mare Explorer, a proposed mission to send a floating lander to a sea on Titan.
Her appointment as chief scientist marks a return to NASA for Dr. Stofan. From 1991 through 2000, she held a number of senior scientist positions at NASA's Jet Propulsion Laboratory in Pasadena, Calif., including chief scientist for NASA's New Millennium Program, deputy project scientist for the Magellan Mission to Venus, and experiment scientist for SIR-C, an instrument that provided radar images of Earth on two shuttle flights in 1994.
Stofan holds master and doctorate degrees in geological sciences from Brown University in Providence, R.I., and a bachelor's degree from the College of William and Mary in Williamsburg, Va. She has received many awards and honors, including the Presidential Early Career Award for Scientists and Engineers. Stofan has authored and published numerous professional papers, books and book chapters, and has chaired committees including the National Research Council Inner Planets Panel for the recent Planetary Science Decadal Survey and the Venus Exploration Analysis Group.
Dr. Catherine Woteki is Under Secretary for United States Department of Agriculture's (USDA) Research, Education, and Economics (REE) mission area, as well as the Department's Chief Scientist. Her responsibilities include oversight of the four agencies that comprise REE, the Agricultural Research Service (ARS), National Institute for Food and Agriculture (NIFA), Economic Research Service (ERS), and National Agriculture Statistics Service (NASS.) The National Agriculture Library and National Arboretum also fall under this mission area. Before joining USDA, Dr. Woteki served as Global Director of Scientific Affairs for Mars, Incorporated, where she managed the company's scientific policy and research on matters of health, nutrition, and food safety. From 2002 to 2005, she was Dean of Agriculture and Professor of Human Nutrition at Iowa State University, where she was also the head of the Agriculture Experiment Station. Dr. Woteki served as the first Under Secretary for Food Safety at USDA from 1997 to 2001, where she oversaw U.S. Government food safety policy development and USDA's continuity of operations planning. Dr. Woteki also served as the Deputy Under Secretary for REE at USDA in 1996. Prior to going to USDA, Dr. Woteki served in the White House Office of Science and Technology Policy as Deputy Associate Director for Science from 1994 to 1996. During that time she co-authored the Clinton Administration's policy statement, "Science in the National Interest." Dr. Woteki has also held positions in the National Center for Health Statistics of the U.S. Department of Health and Human Services (1983 to 1990), the Human Nutrition Information Service at USDA (1981 to 1983), and as Director of the Food and Nutrition Board of the Institute of Medicine at the National Academy of Sciences (1990 to 1993). During her tenure as Director of the Food and Nutrition Board she had direct responsibility for twenty-seven studies and co-authored a nutrition book entitled Eat for Life which became a Book of the Month Club selection. Dr. Woteki's research interests include nutrition, food safety policy, risk assessment, and health survey design and analysis. She is the author of over sixty refereed scientific articles and twelve books and technical reports. In 1999, Dr. Woteki was elected to the Institute of Medicine of the National Academy of Sciences, where she has chaired the Food and Nutrition Board (2003 to 2005). She received her M.S. and Ph.D. in Human Nutrition from Virginia Polytechnic Institute and State University (1974). Dr. Woteki received her B.S. in Biology and Chemistry from Mary Washington College (1969).